TMX2 and adrenal cortex carcinoma: TMX2 was found to be a beneficial prognosis factor in KIRAN, KIRC (HR <1, p <0.05), and played a risk factor for ACC, BLCA, BRCA, HNSC, LAML, LIHC, LUAD or UVM (HR >1, p <0.05, Figure 3B).